NRx Pharmaceuticals, Inc. (NRXPW)

NASDAQ: NRXPW · Real-Time Price · USD · Warrants
0.1382
+0.0182 (15.17%)
At close: Nov 5, 2025, 4:00 PM EST
0.1380
-0.0002 (-0.14%)
After-hours: Nov 5, 2025, 4:00 PM EST
15.17%
Market Cap63.23M
Revenue (ttm)n/a
Net Income (ttm)-33.79M
Shares Out 19.71M
EPS (ttm)-2.35
PE Ration/a
Forward PE4.16
Dividendn/a
Ex-Dividend Daten/a
Volume1,347
Open0.1298
Previous Close0.1200
Day's Range0.1297 - 0.1400
52-Week Range0.0500 - 0.5000
Beta1.74
Analystsn/a
Price Targetn/a
Earnings Daten/a

About NRXPW

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country United States
Stock Exchange NASDAQ
Ticker Symbol NRXPW
Full Company Profile

News

There is no news available yet.